5HT3 Antagonism and Auditory Gating in Schizophrenia

Completed · Not applicable

Conditions studied: Schizophrenia

In brief

The target groups in this study are brain waves and neurotransmitters (chemical messengers) in the brain. Subjects with diagnosed with schizophrenia will be studied. The study will help understand more about normal brain functioning and how that functioning differs in people with schizophrenia. Another purpose of this study is to determine how the altered brain functioning in schizophrenia contributes the symptoms found in the illness.

Key facts

Study ID

NCT00018850

Run by

US Department of Veterans Affairs

Starts

1998-06-01

Expected to finish

2003-06-01

Last updated by the study team

2009-01-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• VAMC — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.